Efecto de Comorbilidad y Polifarmacia en la Trayectoria de Envejecimiento
Ibero Ciencias - Revista Científica y Académica - ISSN 3072-7197 · 11.03.2026 · 5 (1) · 3269-3278
DOI: 10.63371/ic.v5.n1.a826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ibero Ciencias - Revista Científica y Académica - ISSN 3072-7197, online erschienen am 11.03.2026. Verfasst von Enid Asvany Guzmán Caballero und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Population aging has been accompanied by an increase in the prevalence of chronic diseases, which favored the appearance of comorbidity and polypharmacy in older adults. These conditions were associated with functional decline, frailty, and unhealthy aging trajectories. The objective of the study was to evaluate the effect of comorbidity and polypharmacy on the aging trajectory of older adults, from the life course approach. A mixed, cross-sectional, descriptive and analytical study was developed, with a non-probabilistic convenience sample of 40 older adults between 60 and 90 years of age, users of the Day House of the DIF Toluca and the Geriatrics consultation of the ISSSTE General Hospital, Toluca. The information was collected through structured interviews, which included sociodemographic data, pathologies, pharmacological consumption and self-medication. Functional capacity was assessed using the Katz, Lawton and Brody scales, while the aging trajectory was classified based on specialized theoretical references and the Clinical Frailty Scale of Dalhousie University. The results showed a predominance of the female gender and a high prevalence of chronic-degenerative diseases, mainly arterial hypertension and diabetes mellitus. More than half of the sample had three or more diseases and simultaneous consumption of multiple drugs. It was observed that comorbidity and polypharmacy were associated with pathological and fragile aging trajectories, as well as with greater deterioration of functional capacity. It was concluded that comorbidity and polypharmacy negatively influenced the aging trajectory, which reinforces the need to strengthen preventive strategies and comprehensive interventions aimed at improving the quality of life of older adults.
Zitieren
APA
Caballero, E. A. G., Rosete, M. G., & Hernández, H. J. Á. (2026). Efecto de Comorbilidad y Polifarmacia en la Trayectoria de Envejecimiento. Ibero Ciencias - Revista Científica y Académica - ISSN 3072-7197, 5(1), 3269-3278. https://doi.org/10.63371/ic.v5.n1.a826
Vancouver
Caballero EAG, Rosete MG, Hernández HJÁ. Efecto de Comorbilidad y Polifarmacia en la Trayectoria de Envejecimiento. Ibero Ciencias - Revista Científica y Académica - ISSN 3072-7197. 2026;5(1):3269-3278. doi:10.63371/ic.v5.n1.a826
BibTeX
@article{Caballero2026,
author = {Caballero, Enid Asvany Guzmán and Rosete, Moisés García and Hernández, Helí Jesset Álvarez},
title = {Efecto de Comorbilidad y Polifarmacia en la Trayectoria de Envejecimiento},
journal = {Ibero Ciencias - Revista Científica y Académica - ISSN 3072-7197},
year = {2026},
volume = {5},
number = {1},
pages = {3269--3278},
doi = {10.63371/ic.v5.n1.a826}
}
EUVIMED